Status:
COMPLETED
Ozone Therapy for Oral Mucositis in Patients Receiving Head and Neck Cancer Radio- and Chemotherapy
Lead Sponsor:
University of Pavia
Conditions:
Oral Mucositis
Oral Stomatitis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Oral mucositis is a frequent and painful side effect of radio- and chemotherapy, especially in patients with head and neck cancer. It can cause severe discomfort, difficulty eating and swallowing, inf...
Detailed Description
Oral mucositis and stomatitis are common toxicities in patients receiving radiotherapy, chemotherapy, or combined treatment for cancer, particularly in the head and neck region. These lesions signific...
Eligibility Criteria
Inclusion
- Age ≥ 18 years.
- Currently undergoing oncologic therapy (radiotherapy, chemotherapy, or combined treatment).
- Presence of oral mucositis or stomatitis of at least WHO grade 1 at baseline evaluation.
Exclusion
- Pregnant women.
- Patients with Down syndrome.
- Patients with epilepsy.
- Patients with cardiac pacemakers.
- Patients with marked sensitivity to electrical current.
- Non-cooperative patients.
Key Trial Info
Start Date :
October 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 20 2025
Estimated Enrollment :
58 Patients enrolled
Trial Details
Trial ID
NCT07199712
Start Date
October 1 2025
End Date
November 20 2025
Last Update
November 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Unit of Orthodontics and Pediatric Dentistry - Section of Dentistry - Department of Clinical, Surgical, Diagnostic and Pediatrics - University of Pavia
Pavia, Lombardy, Italy, 27100